help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 22, 2007
Endocrinology, doi:10.1210/en.2006-1149
A more recent version of this article appeared on June 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
148/6/2904    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshida, K.
Right arrow Articles by Ishida, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshida, K.
Right arrow Articles by Ishida, T.

Submitted on August 21, 2006
Accepted on February 14, 2007

Pancreatic Glucokinase is Activated by Insulin-like Growth Factor-I

Kazuya Yoshida, Koji Murao*, Hitomi Imachi, Wen M. Cao, Xiao Yu, Junhua Li, Rania A.M. Ahmed, Noriko Kitanaka, Norman C.W. Wong, Terry G. Unterman, Mark A. Magnuson, and Toshihiko Ishida

Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Kagawa University, 1750-1, Miki-CHO, Kita-gun, Kagawa, Japan.; Departments of Medicine and Biochemistry & Molecular Biology, Faculty of Medicine, University of Calgary, Health Sciences Center, 3330 Hospital Drive NW, Calgary, Alberta, Canada, T2N 4N1.; Departments of Medicine and Physiology and Biophysics, University of Illinois at Chicago College of Medicine and Jesse Brown VA Medical Center, Chicago, Illinois 60612, USA; Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee

* To whom correspondence should be addressed. E-mail: mkoji{at}kms.ac.jp.

Glucokinase (GK) plays a key role in the regulation of glucose utilization and glucose stimulated insulin secretion in pancreatic islet cells. Gene-targeting of the insulin-like growth factor I receptor (IGF-IR) down regulated pancreatic islet GK activity. That finding prompted us to examine potential mechanism that may control GK gene activity using an islet cell line, INS-1 known to express IGF-IR. Exposure of these cells to IGF-I induced GK protein expression and activity of the enzyme in a dose-dependent manner. In addition, IGF-I induced activity of a reporter construct containing the GK promoter in parallel with the effect on endogenous GK mRNA levels. The stimulatory effect of IGF-I on GK promoter activity was abrogated by wortmannin, and LY294002, specific inhibitors of PI3-K. Exposure of cells to IGF-I elicited a rapid phosphorylation of Akt and FoxO1, a known target of Akt signaling. Constitutively active Akt stimulates the activity of the GK promoter and a dominant-negative mutant of Akt or mutagenesis of a FoxO1 response element in the GK promoter abolished the ability of IGF-I to stimulate the promoter activity. Furthermore, cell knock-down of FoxO1 with siRNA disrupted the effect of IGF-I on GK expression. These results demonstrate that PI3-K/Akt/FoxO1 pathway contribute to the regulation of GK gene expression in response to IGF-I stimulation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society